Merck Press Releases

Published on May 14, 2016 - 03:24 GMT

Merck and the Mectizan Donation Program Donate $1 Million to the END Fund for Efforts to Help Eliminate River Blindness in Africa

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the company, together with the Mectizan Donation Program, is donating $1 million to the END Fund in support of efforts in Africa to …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a new supplemental Biologics License Application (sBLA) for …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck Names Sanat Chattopadhyay President of Merck Manufacturing Division; Will Succeed Willie A. Deese Who Will Retire

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the appointment of Sanat Chattopadhyay as executive vice president and president, Merck Manufacturing Division (MMD), effective April 1 …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Sanofi Pasteur and Merck (Known as MSD Outside the United States and Canada) Announce Intent to End Joint Vaccines Operations in ...

KENILWORTH, N.J. & LYON, France--(BUSINESS WIRE)--Sanofi Pasteur and Merck, known as MSD outside the United States and Canada, today announced their intent to end their joint vaccines operations in Europe. Upon concluding their joint venture, both …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck Applauds the U.S. Department of Veterans Affairs (VA) for Broadening Treatment Access for Veterans with Chronic Hepatitis C ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, applauds the U.S. Department of Veterans Affairs (VA) for broadening access to treatment for Veterans with chronic hepatitis C virus (HCV) infection. …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

MSD Animal Health Receives Positive Final Opinion from European Medicines Agency for BRAVECTO™ (fluralaner) Spot-On for Cats and ...

MADISON, N.J.--(BUSINESS WIRE)--MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency has adopted a positive …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck Foundation Awards Grant to American Cancer Society for Program to Improve Access to High-Quality Cancer Care in Underserved ...

KENILWORTH, N.J.--(BUSINESS WIRE)--The Merck Foundation (the Foundation) and the American Cancer Society (ACS) announced today that the Foundation provided a grant of $1.58 million over four years to the ACS to implement a comprehensive Patient Navigation …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck to Present New Findings from Chronic Hepatitis C Clinical Development Programs at The International Liver CongressTM 2016

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the planned presentations of data from the company’s broad chronic hepatitis C virus (HCV) clinical development programs at the …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck Receives 2016 ENERGY STAR Sustained Excellence Award From U.S. Environmental Protection Agency

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that it has received an ENERGY STAR 2016 Partner of the Year – Sustained Excellence Award from the U.S. Environmental Protection Agency …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck to Present New Data for KEYTRUDA® (pembrolizumab) at the American Association for Cancer Research 2016 Annual Meeting

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new research investigating the use of KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, in multiple tumor types, both as …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More Than 30 Data Presentations at ECCMID 2016

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that researchers are scheduled to provide more than 30 scientific data presentations on the company’s established and investigational …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck to Hold First-Quarter 2016 Sales and Earnings Conference Call on May 5

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its first-quarter 2016 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Thursday, May 5. …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck Announces FDA Acceptance of Biologics License Application for Investigational House Dust Mite Sublingual Allergy ...

KENILWORTH, N.J. – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for MK-8237, Merck’s house dust mite …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) in Recurrent or Metastatic Head and ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck’s ZEPATIER™ (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of results from C-EDGE Head-to-Head, the company’s comparative, Phase 3, open-label clinical trial evaluating the …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck Announces Results From Phase 3 Studies of ZEPATIER™ (Elbasvir and Grazoprevir) in Chronic Hepatitis C Patient Populations at ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the presentation of results from two Phase 3 clinical trials evaluating ZEPATIER™ (elbasvir and grazoprevir) 50mg/100mg tablets in …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for KEYTRUDA® (pembrolizumab) in Classical ...

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to KEYTRUDA® (pembrolizumab), the company’ …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck Statement on Blueprint Project Findings Presented at the American Association for Cancer Research 2016 Annual Meeting

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, is proud to be a part of the Blueprint PD-L1 Assay Comparison Project, an important initiative to compare several new diagnostic tests for the immune …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Merck Animal Health to Acquire Worldwide Rights to Whisper® Veterinary Stethoscope System

MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced plans to acquire worldwide rights for the Whisper® Veterinary Stethoscope System from Minnesota-based Geissler Companies …

Distribution channels: Companies

Published on May 14, 2016 - 03:23 GMT

Christina Applegate and Merck Urge Insomnia Sufferers to Learn “Why They’re So Awake”

KENILWORTH, N.J. – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it is teaming up with Emmy® Award-winning actress Christina Applegate to educate the millions of Americans struggling with insomnia. An insomnia …

Distribution channels: Companies

Merck Press Releases Distributed by EIN Presswire